✨ Free AI Report
Elekta AB: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Elekta AB
Company Research

Elekta AB: Business Overview, Financials & Competitive Analysis

Elekta AB scores 6/10 on the AskCyborg Cyborg Score (Solid). Restructuring-driven cost reduction and order quality improvements position Elekta for improved margins and profitability post-2026/27, contingent on successful execution and market recovery in key geographies. Elekta maintains a strong market position in specialized medical technology with stable revenue around SEK 18 billion and established global distribution. However, recent strategic challenges.

What is Elekta AB's industry? Elekta AB (elekta.com) operates in Medical Devices - Oncology & Radiation Therapy. AskCyborg classifies Elekta AB under Medical Devices - Oncology & Radiation Therapy in its company registry.

Elekta AB is a Swedish medical technology company specializing in advanced cancer care and neuroscience solutions. The company develops and provides radiotherapy systems, clinical software, and comprehensive treatment...

6/ 10Solid

Cyborg Score thesis

Restructuring-driven cost reduction and order quality improvements position Elekta for improved margins and profitability...

Read the full analyst-debate transcript →
Industry Medical Devices - Oncology & Radiation Therapy
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Elekta AB Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Elekta AB

AskCyborg analysts argue the bull and bear cases for Elekta AB across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Elekta AB OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Elekta AB Overview

Pro stress-test →

Elekta AB is a Swedish medical technology company specializing in advanced cancer care and neuroscience solutions. The company develops and provides radiotherapy systems, clinical software, and comprehensive treatment solutions for oncology and neurological disorders, serving healthcare providers globally across North America, Europe, Asia-Pacific, and other regions.

Strategic Profile

Pro stress-test →

Elekta operates through four core product lines: Oncology (linear accelerators and imaging systems), Brachytherapy (internal radiation treatment), Neuroscience (neurological diagnosis and treatment), and Software (clinical workflow and treatment planning solutions). The company is undergoing strategic restructuring with 450-employee reduction targeting over SEK 500 million in annual cost savings while managing near-term headwinds in key markets like China and FX pressures.

Competitive Landscape

Pro stress-test →

Elekta competes in the specialized medical radiation therapy and oncology software markets against established players including Siemens Healthineers, Stryker, and other healthcare equipment manufacturers. The company differentiates through integrated treatment solutions and specialized software platforms. Market consolidation and globalization are ongoing trends, with Elekta positioned as a specialized focused player rather than diversified conglomerate.

Industry Context

Elekta AB operates in Medical Devices - Oncology & Radiation Therapy.

Key facts

Founded: 1972 · Headquarters: Stockholm, Sweden · Employees: Approximately 3,900 (post-reduction: ~3,450) · Revenue: $1.74B (TTM) · Market cap: $2.34B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Elekta AB.

  • Strategic restructuring: 450 employees being reduced with SEK 500M+ annual cost savings starting Q1 2026/27 as company simplifies organizational structure
  • Order book quality initiative: SEK 2.2 billion order cancellation from firmer interpretation of criteria to improve predictability and profitability with no revenue impact
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2026Strategic Update announced focusing on growth initiatives and organizational restructuring with cost reduction targets
  • November 2025Q2 2025/26 results showed 6.2% revenue decline YoY to SEK 4.07B; order book review completed with SEK 2.2B adjustments
  • +1 moreTrack every material event for Elekta AB as it happens. Explore monitoring →
Get alerted when Elekta AB has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Radiation Therapy SystemsDiversified healthcare equipment and imaging solutions→Orthopedic & Surgical EquipmentMedical device manufacturer with broad surgical portfolio→Medical Device SolutionsSpecialized surgical and oncology equipment→

Compare Elekta AB with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Elekta AB operates in Medical Devices - Oncology & Radiation Therapy. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Oncology & Radiation Therapy research →
NEW · MCP server

Ask your AI assistant about Elekta AB

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Elekta AB and its top competitor on Cyborg Score”
“What did Elekta AB do this quarter?”
“Is Elekta AB a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Elekta AB do?+
Elekta AB is a Swedish medical technology company specializing in advanced cancer care and neuroscience solutions. The company develops and provides radiotherapy systems, clinical software, and comprehensive treatment...
What is Elekta AB's Cyborg Score?+
Elekta AB has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Elekta AB's main competitors?+
Named competitors include Radiation Therapy Systems, Orthopedic & Surgical Equipment, Medical Device Solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full Elekta AB research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Elekta AB research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Elekta AB over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.